Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1

Active Ingredient:: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetam
Form:: CAPSULE, EXTENDED RELEASE
Brand:: Mixed Salts of a Single Entity Amphetamine Product XR
Origin:: USA

Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 (Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetam CAPSULE, EXTENDED RELEASE) 1.25 mg/1

Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 is an extended-release capsule designed for oral use. It contains a combination of amphetamine salts, commonly used for attention deficit hyperactivity disorder (ADHD) management. This medication is manufactured by SpecGx LLC in the USA.

Strength

1.25 mg/1

Pack Size

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-8951-01)

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 is primarily used for the treatment of ADHD. The extended-release formulation is designed to provide a steady release of the active ingredients over time, which may help in managing symptoms throughout the day. This medication is often prescribed to improve focus, attention, and impulse control in individuals with ADHD.

Side Effects

Common effects of Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 may include increased alertness, improved concentration, and reduced hyperactivity. Some users may experience side effects such as decreased appetite, insomnia, or mild stomach upset. The extended-release formulation is intended to minimize fluctuations in drug levels, potentially reducing the likelihood of side effects.

Precautions & Warnings

It is important to handle Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 with care, following the prescribed dosage and administration instructions. This medication should be stored in a cool, dry place away from direct sunlight and out of reach of children. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Mixed Salts of a Single Entity Amphetamine Product XR 1.25 mg/1 may interact with certain medications, including other stimulants, antidepressants, and some over-the-counter cold and allergy medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.

Frequently Asked Questions

This medication is primarily used for the management of ADHD, helping to improve focus and attention.

This medication is taken orally, typically once daily in the morning. Follow your healthcare provider's instructions for proper use.

Common side effects may include decreased appetite, insomnia, and mild stomach upset. Always consult a healthcare provider for personalized advice.

This medication may interact with certain drugs. Inform your healthcare provider about all medications you are taking to avoid potential interactions.

It is advisable to avoid alcohol while using this medication to prevent potential adverse effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.